The chemical class known as LOC100041291 Activators, also recognized under the alias eukaryotic translation initiation factor 3, subunit B activators, includes a specialized group of compounds that are designed to target and modulate the activity of the LOC100041291 gene, which encodes for a subunit of the eukaryotic translation initiation factor 3 (eIF3b). eIF3b is integral to the initiation phase of protein synthesis, playing a pivotal role in the assembly of the translation initiation complex and the recruitment of mRNA to the ribosome. The activators within this class are characterized by their ability to influence the expression and functionality of LOC100041291, thereby impacting the protein synthesis machinery's efficiency and overall cellular protein production. The interaction between these activators and LOC100041291 involves complex molecular dynamics, potentially including direct engagement with the gene or its regulatory elements, alterations in the transcriptional or translational machinery, or modifications in the post-translational processing of eIF3b, leading to enhanced or altered functionality of the translation initiation complex.
Delving into the specifics of LOC100041291 activators necessitates an in-depth understanding of the molecular mechanisms underlying protein synthesis and the regulation of gene expression at the translational level. By modulating the activity of LOC100041291, these activators can have profound implications for the cellular processes dependent on protein synthesis, potentially influencing cell growth, differentiation, and response to various external stimuli. This modulation is critical for understanding the role of eIF3b in cellular physiology and its interaction with other components of the translational machinery. The study of LOC100041291 activators thus provides valuable insights into the regulation of protein synthesis, shedding light on the intricate control mechanisms that govern this essential cellular process and contributing to a broader understanding of the molecular basis of cellular function and the complex interplay between genetic regulation and protein production.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid regulates gene expression by activating nuclear receptors and could influence the expression of genes involved in translation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
As a DNA methyltransferase inhibitor, this compound could hypothetically upregulate genes by reducing DNA methylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which may modulate transcription factors and alter gene expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can inhibit GSK-3, possibly stabilizing transcription factors and influencing gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in the control of protein synthesis and may affect translation-related genes indirectly. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate inhibits histone deacetylases, potentially leading to changes in chromatin structure and gene expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid that can regulate genes through glucocorticoid response elements in the DNA. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that could alter the activity of transcription factors, potentially impacting gene expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits proteasomes, potentially leading to the accumulation of regulatory proteins that influence gene transcription. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 selectively inhibits TGF-β receptor kinases, potentially affecting downstream signaling pathways and gene expression. | ||||||